The largest database of trusted experimental protocols

173 protocols using superdex 200 increase 10 300 column

1

Expression and Purification of HIV-1 Trimer Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
1-18 IgG was expressed by transient transfection in Expi293 cells (Thermo Fisher) and purified from transfected cell supernatants using a HiTrap MabSelect Protein A column (GE Life Sciences). Fab fragments were isolated as described (Diskin et al., 2011 (link)) after papain cleavage of 1-18 IgG, removal of Fc by protein A chromatography, and then purification by size exclusion chromatography (SEC) on a Superdex-200 Increase 10/300 column (GE Life Sciences) equilibrated with TBS (20 mM Tris pH 8.0, 150 mM NaCl). 1-55 Fab was expressed as a light-chain C-terminal His6-tagged Fab by transient transfection in 293-6E cells (National Research Council of Canada) and purified from supernatants using Ni2+-NTA affinity chromatography (GE Life Sciences) followed by SEC purification with a Superdex-200 Increase 10/300 column equilibrated with TBS. All Fabs were stored at 4°C.
BG505SOSIP.664 trimer was stably expressed in Chinese hamster ovary cells (kind gift of J.P. Moore and A. Cupo) as described (Chung et al., 2014 (link)) and purified from cell culture supernatant over a 2G12 immunoaffinity column followed by SEC purification on a Superdex-200 16/60 column (GE Life Sciences) equilibrated with TBS. RC1SOSIP.664 was expressed by transient transfection in 293-6E cells and purified as described (Escolano et al., 2019 (link)). Individual SEC fractions of each SOSIP trimer were stored at 4°C.
+ Open protocol
+ Expand
2

Sortase A-mediated Ligation and Characterization of 1NOG-Antibody Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression and purification procedures of Sortase A and 1NOG-His trimer were described previously (38 (link)). Briefly, the proteins were produced in Rosetta2 E. coli cells (Novagen) and purified with Ni NTA-agarose beads (Qiagen) and Superdex 200 increase 10/300 column (GE Healthcare). For protein ligation reaction, GPCysRRLL-LPETG-Strep and GGGGGSGSP-1NOG-His trimer were mixed with a molar ratio of 3:1 in TBS buffer plus 2 mM CaCl2 and 1 μM purified Sortase A. After incubation at room temperature for 50 minutes, 2 mM EGTA (final concentration) was added, and the reaction mixture was immediately purified with a Superdex 200 increase 10/300 column (GE Healthcare) to obtain GPCysRRLL-LPETG-1NOG trimer.
To make samples of GPCysRRLL-LPETG-1NOG in complex with antibodies, 5 μg of Sortase A-ligated GPCysRRLL-LPETG-1NOG trimer was incubated with 20 μg of 8.9F-scFv, 12.1F-scFv, 37.2D-scFv, 25.10C-Fab, 19.7E-Fab, or 37.7H-Fab at room temperature overnight. Excess scFv or Fab was removed using 100 KDa cut-off Amicon centrifugal filters (EMD Millipore). The concentrated complexes were further characterized by electron microscope analysis.
+ Open protocol
+ Expand
3

Purification and Characterization of ToxRSp-ox

Check if the same lab product or an alternative is used in the 5 most similar protocols
ToxRp‐ox and ToxSp were purified according to the protocol described before and pooled in a 1:2 ratio with excess of ToxSp. To get rid of unbound ToxSp, the sample was further purified using a Superdex 200 Increase 10/300 column (GE healthcare). The resulting fractions were pooled and concentrated to 0.1 ml, containing 18 mg/ml of ToxRSp‐ox heterodimer using Amicon Ultra Centricons with a 3 kDa cutoff. The sample was loaded on a Superdex 200 Increase 10/300 column (GE healthcare) with a flow rate of 0.5 ml/min performed on a ÄKTA pure 25 (GE healthcare) connected to the miniDAWN Treos II MALS detector (Wyatt). The buffer used for the MALS‐SEC measurement contained 20 mM Tris, 150 mM sodium chloride, pH 7.5. The chromatogram resulted in a single peak eluting after 16.19 ml. The hydrodynamic radius determined by the MALS detector leads to a molecular weight of about 28 kDa, suggesting a heterodimer formation of ToxRSp‐ox.
+ Open protocol
+ Expand
4

Characterizing PapA Polymerization by SEC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples of purified PapDHis:PapA wild-type, Val18AzF, Asn96AzF, Asp126AzF, and Val155 AzF were left to polymerize at 20°C for 16 hr at a concentration of 38 μM. These samples (100 μl) were loaded consecutively onto a Superdex 200 10/300 increase column (GE Healthcare) to assess whether PapA has undergone DSE. To unambiguously identify the species responsible for each peak, a sample of PapD:PapA Val18AzF was run on a SEC-MALS instrument (Wyeth) also using a Superdex 200 10/300 increase column (GE Healthcare) and the molecular weight of each peak was derived using the manufacturer’s software.
+ Open protocol
+ Expand
5

Characterization of Monoclonal Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty monoclonal antibodies discovered by single B cell technology were selected for characterization based on their binding specifies to HKU1-S, MERS-S and SARS-1-S (monospecific, bi-specific or tri-specific), diversity of heavy and light chain CDR3s, and high frequency rates in the B cell repertoire (independently isolated by the probes more than 2 times). The individual VH sequence of selected IgGs was cloned into a mammalian expression plasmid pVRC8400 containing HRV 3C cleavage site in the hinge, and human IgG1 Fc domain. VL sequences were also cloned into pVRC8400 with human CL. Paired VH and VL in a 1:1 ratio were co-transfected transiently into FreeStyle293F cells as previously described. The supernatant was harvested six days post-transfection and IgGs were purified with Protein A agarose (ThermoFisher). IgGs were eluted with 100 mM glycine, pH 3 into 1/10th volume 1 M Tris-HCl pH 8.0. IgGs were then buffer exchanged into PBS pH 7.4. Fabs were generated by digesting the IgGs with HRV 3C protease at 4°C. Fc was removed by passing digests over fresh Protein A agarose, leaving the Fab in the flowthrough, which was further purified by SEC using a Superdex 200 increase 10/300 column (GE Healthcare) in PBS buffer, pH 7.4.
+ Open protocol
+ Expand
6

Superdex 200 FPLC Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
FPLC was performed as described in our previous report [29 ]. Briefly, an ÄKTA pure FPLC System (GE Healthcare, Munich, Germany) equipped with a Superdex 200 Increase 10/300 column (GE Healthcare, Munich, Germany) was used with PBS as mobile phase. After loading, HDL samples were separated with a constant flow of 0.5 mL/min, and 0.5 mL fractionation between of 9 to 13.5 mL elution volume were collected. The software UNICORN (GE Healthcare, Munich, Germany) was used for analysis.
+ Open protocol
+ Expand
7

Site-Specific Protein Conjugation via Sialidase

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-FcX–HIPS–azide (63.3 nmol, 1 equiv., 11.9 ml) and ST sialidase (316.9 nmol, 5 equiv., 16 ml), both in PBS buffer, were mixed together and concentrated to ~25 mg ml−1 using 10,000 molecular weight cut-off Amicon spin filters. The final mixture (~0.92 ml) was incubated at 25 °C in the dark with shaking at 500 r.p.m. for 3 d. The reaction was monitored by SDS–PAGE and purified by size exclusion chromatography using a Superdex 200 increase 10/300 column on the ÄKTA pure chromatography system in PBS (GE Healthcare Life Sciences), followed by protein A chromatography. Final conjugates were buffer exchanged to PBS buffer with PD-10 columns and 0.2-μm was syringe filtered.
+ Open protocol
+ Expand
8

Protein Molecular Weight Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
5 mg/ml (0.24 mM) of purified protein (wild-type OrnVc, OrnVc-D12A, or OrnVc-R130A) was injected onto a Superdex 200 Increase 10/300 column (GE Healthcare) equilibrated with gel filtration buffer (25 mM Tris-Cl, pH 7.5, 150 mM NaCl). Samples were run continuously at a flow rate of 0.75 ml/min through the gel filtration column coupled to a static 18-angle light scattering detector (DAWN HELIOS-II) and a refractive index detector (Optilab T-rEX), with data being collected every second. Data analysis was performed with ASTRA VI, yielding the molar mass and mass distribution (polydispersity) of the sample, using monomeric BSA (Sigma; 5 mg/ml) to normalize the light scattering detectors and as a control sample.
+ Open protocol
+ Expand
9

SEC-MALLS Analysis of Timeless Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For SEC-MALLS experiments a Superdex 200 Increase 10/300 column (GE Healthcare) was coupled with a DAWN HELEOS II MALLS detector with a 664 nm laser light source, eight fixed-angle detectors and an Optilab T-rEX differential refractometer (Wyatt Technology) at 25°C. A total of 1–2 mg/ml (100 μl injection) of Timeless(1–1208Δ239-330) and Timeless(1–463Δ239-330) were analysed in 25 mM Hepes 7.2, 150 mM KCl, 50 mM Arginine, 50 mM Glutamate. The collected data were analysed and processed using ASTRA 6 (Wyatt Technology).
+ Open protocol
+ Expand
10

SEC-MALS Analysis of Purified Atg40

Check if the same lab product or an alternative is used in the 5 most similar protocols
SEC-MALS was performed with the HPLC system (Shimadzu) equipped with a Shimadzu LC-20AD pump, a UV detector (SDP-20A), a MALS detector (DAWN HELEOS II, Wyatt Technology), and a differential refractive index (RI) detector (RI-501, Shodex). The sample was applied to Superdex 200 increase 10/300 column (GE Healthcare) equilibrated in buffer J at room temperature. The data analysis was carried out using Wyatt ASTRA software using a dn/dc value (protein 0.1853, DDM 0.1435) and UV Ext. coefficient (purified Atg40 1.220).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!